Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-16

Clinical Trial Update: The Effect of Uric Acid Lowering in Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of uric acid lowering in individuals with type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • uric acid lowering therapy

Snippet

Sponsor: University Health Network, Toronto | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED